Behavioral-neuroendocrine-immunologic interactions in myocardial infarction

Medical Hypotheses

Volumn 48, Issue 3, 1997, Pages 209-214

  Goodkin, K ^a   Appels, A ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CYTOKINE; DOXYCYCLINE; FLUOXETINE; FLUVOXAMINE; GANCICLOVIR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NALTREXONE; PAROXETINE; PENICILLIN G; PENTOXIFYLLINE; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; THALIDOMIDE; TRYPTOPHAN;

AUTOIMMUNITY; BEHAVIOR; CORONARY ARTERY DISEASE; DIET; EXHAUSTION; HEART INFARCTION; HUMAN; INFECTION; NEUROENDOCRINE SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW;

EID: 0030970844     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(97)90308-X     Document Type: Article

References (45)

1. Julkunen J, Salonen R, Kaplan G A, Chesney M A, Salonen J T. Hostility and the progression of carotid atherosclerosis. Psychosom Med 1994; 56: 519-525.
2. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J 1988; 9: 758-764.
3. Appels A, ed. Behavioral Observations in Cardiovascular Research. Amsterdam: Swets & Zeitlinger, 1991.
4. Falger P R J, Schouten E G W. Exhaustion, psychological Stressors in the work environment and acute myocardial infarction in adult men. J Psychosom Res 1992; 36: 777-786.
5. Appels A, Falger P R J, Schouten E G W. Vital exhaustion as risk indicator for myocardial infarction in women. J Psychsom Res 1993; 37: 881-880.
6. Kop W J, Appels A, Mendes de Leon C F, de Swart H B, Bar F W. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med 1994; 56: 281-287.
7. Pesonen E, Siitonen O. Acute myocardial infarction precipitated by infectious disease. Am Heart J 1981; 101: 512-513.
8. Spodick D H, Flessas A P, Johnson M M. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 1984; 53: 481-482.
9. Mattila K J. Viral and bacterial infections in patients with acute myocardial infarction. J Int Med 1989; 225: 293-296.
10. Paunio K, Impivaara O, Tiesko J, Mäki J. Missing teeth and ischaemic heart disease in men aged 45-64 years. Eur Heart J 1993; 14 (supplement K): 54-56.
11. DeStefano F, Anda R F, Kahn H S, Williamson D F, Russell C M. Dental disease and risk of coronary heart disease and mortality. Br Med J 1993; 306: 688-691.
12. Saikku P, Matilla K, Nieminen M S et al. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii: 983-985.
13. Thom D H, Grayston J T, Siscovick D S, San-Pin Wang, Weiss N S, Daling J R. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. J Am Med Assoc 1992; 268: 68-72.
14. Saikku P, Keinonen M, Tenkanen L et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Int Med 1992; 116: 273-278.
15. Grayston J T, Kuo C C, Campbell L A, Benditt E P. Chlamydia pneumoniae, strain TWAR and atherosclerosis. Eur Heart J 1993; 14 (supplement K): 66-71.
16. McGovern P G, Folsom A R, Sharar E, Rosamond W D, Heiss G. Relation of measure of vital exhaustion to carotid wall thickness: The Atherosclerosis Risk in Communities (ARIC) Study. Poster presented at the 34th Annual Conference on Cardiovascular Disease Epidemiology and Prevention, Tampa Bay, Florida, USA, March, 1994.
17. Havlik R J, Blackwelder W C, Kaslow R, Castelli W. Unlikely association between clinically apparent herpesvirus infection and coronary incidence at older ages. The Framingham Study. Arteriosclerosis 1989; 9: 877-880.
18. Hendrix M G R, Salimans, M M, van Boven C P A, Bruggeman C A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23-28.
19. Speier E, Modali R, Eng-Shang Huang et al. Potential role of human cytomegalovirus and p53 interaction in coronary re-stenosis. Science 1994; 265: 391-394.
20. Kemeny M E, Cohen F, Zegans L S, Conant M A. Psychological and immunological predictors of genital herpes recurrence. Psychosom Med 1989; 51: 195-208.
21. Bonneau R H, Sheridan J F, Feng N, Glaser R. Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection. Brain Behav Immun 1991; 5: 170-192.
22. Irwin M, Hauger R L, Jones E, Provencio M, Britton K T. Sympathetic nervous system mediates central corticotropin-releasing factor induced suppression of natural killer cell toxicity. J Pharm Exp Ther 1990; 255: 101-107.
23. Goodkin K, Antoni M, Helder L, Sevin B. Psychoneuroimmunological aspects of disease progression among women with human papillomavirus-associated cervical dysplasia and human immunodeficiency virus type 1 co-infection. Int J Psychiat Med 1993; 23: 119-148.
24. Leinonen M. Pathogenic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J 1993; 14 (supplement K): 57-61.
25. St Pierre B A, Kasper C E, Lindsey A M. Fatigue mechanisms in patients with cancer: effects of tumor necrosis factor and exercise on skeletal muscle. Oncol Nurs Forum 1992; 19: 419-425.
26. Dezube B J, Pardee A B, Chapman B et al. The NIAID AIDS Clinical Trials Group. Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J Acquir Immun Defic Syndr 1993; 6: 787-794.
27. Mildvan D, Machado S O, Wilets I, Grossberg S E. Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992; 339: 453-456.
28. Qingbo Xu, Willeit J, Marosi M et al. Association of serum antibodies to heat shock protein 65 with carotid atherosclerosis. Lancet 1993; 341: 255-259.
29. Fletcher M A, Mosley J W, Hassett J et al. Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Group. Blood 1992; 80: 831-840.
30. Takeichi N, Ba D, Suzuki K, Kobayashi H. The arrest of spontaneously hypertensive rats with a deficient production of thymic factors. Acta Pathol Japan 1985; 35: 351-360.
31. Tuttle R S, Boppana D P. Antihypertensive effect of interleukin-2. Hypertension 1990; 15: 89-94.
32. Saphier D. Behavioral and endocrine effects of interferon-α. First Meeting of the Psychoneuroimmunology Research Society Program and Abstracts, Miami, Florida, November 16-20, 1994, Abstract #A.28.
33. 1-opioid receptors in the rat. Eur J Pharm 1993; 236: 183-191.
34. 1A agonists is mediated by sympathomedullary activation. J Pharm Exp Ther 1994; 270: 905-917.
35. Williams R B. Neurobiology, cellular and molecular biology, and psychosomatic medicine. Psychosom Med 1994; 56: 308-315.
36. Muldoon M F, Manuck S B, Matthews K M. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br Med J 1990; 301: 309-314.
37. Horrobin D F. Lowering cholesterol concentrations and mortality. Br Med J 1990; 301: 554.
38. Shor-Posner G, Feaster D, Blaney N et al. Hypocholesterolemia and psychological distress in HIV-1 disease. In: Tenth International Conference on AIDS. August 7-12, 1994. Book of Abstracts. The Global Challenge of AIDS: Together for the Future, Vol.1. Abstract #PB0208. Yokohama: Conference Organizing Committee, 1994: 195.
39. 6 status on psychological distress in a longitudinal study of HIV-1 infection. Int J Psychiat Med 1994; 24: 189-202.
40. Baldewicz T, Goodkin K, Feaster D et al. Plasma pyridoxine activity is related to psychological distress in recently bereaved homosexual men. Psychosom Med 1995; 57: 69.
41. Engelberg H. Low serum cholesterol and suicide. Lancet 1992; 339: 727-729.
42. Merigan T C, Renlund D G, Keay S et al. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N Engl J Med 1992; 326: 1182-1186.
43. Polis M A, Masur H. Promising new treatments for cytomegalovirus retinitis. J Am Med Assoc 1995; 273: 1457-1458.
44. Dinarello C A, Gelfand J A, Wolff S M. Anticytokine strategies in the treatment of systemic inflammatory response syndrome. J Am Med Assoc 1995; 269: 1829-1835.
45. Abraham E, Wunderink R, Silverman H et al. The TNF-α MAb Sepsis Study Group. Efficacy and safety of monoclonal antibody to human tumor necrosis factor a in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial. J Am Med Assoc 1995; 273: 934-941.